Fimmic, a Helsinki, Finland-based medtech company developing Deep Learning AI solutions for digital medical microscopy, closed a €5M in funding.
The round was led by new investor Ascend Capital Partners, with participation from existing investors ACME Investments and STO-Rahoitus.
The company intends to use the funds to accelerate scaling of its WebMicroscope® AI Cloud for tissue diagnostics.
Led by Kaisa Helminen, CEO, Fimmic provides WebMicroscope, a SaaS based commercial platform that supports pathologists and medical researchers in tissue diagnostics through deep learning AI-based image analysis. The platform was launched in spring 2017 and has since been used in a wide range of image analysis applications globally.
Founded in 2013, Fimmic is a spin-off company from the Finnish Institute for Molecular Medicine at the University of Helsinki.
FinSMEs
01/12/2017